This is the authors' abstract. We don't add key points for this paper.
Aims: To determine the factors associated with polypharmacy in individuals aged 60 and over attending at a primary care unit. Methodology: A case-control study was designed with the population served from January 2017 to December 2018 at the “Aragón” Family Medicine Clinic. Results: A total population of 1,657 cases and 1,657 controls was included. The prevalence of excessive polypharmacy was significantly higher (p < 0.001) among patients seen in the MIDE module (n=203, 59.2%; 95% CI 54.2-65.0) and Dentistry (n=188, 48.1%; 95% CI 43.0-52.9). The most frequently prescribed and dispensed medications were nonsteroidal anti-inflammatory drugs, proton pump inhibitors, vitamins, statins, lipid-lowering agents, and non-insulin hypoglycemic agents. A significant association was observed between polypharmacy and the number of services used (OR=2.87; 95% CI 2.40-3.43, p< 0.001 for 2 services, and OR=11.21; 95% CI 6.28-20.03, p< 0.001 for 3 or more services), the presence of multiple morbidities (OR=5.65; 95% CI 4.73-6.76, p< 0.001), and the type of entitlement (OR=0.80; 95% CI 0.69-0.94, p=0.009; family members). Conclusions: The risk factors associated with polypharmacy are linked to the clinical conditions of the patient and the medicalisation process of primary care.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
López-Hernández et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: